Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
4.780
+0.060 (1.27%)
Dec 3, 2024, 1:58 PM EST - Market open

Codexis Revenue

Codexis had revenue of $12.83M in the quarter ending September 30, 2024, with 38.33% growth. This brings the company's revenue in the last twelve months to $64.45M, down -12.86% year-over-year. In the year 2023, Codexis had annual revenue of $70.14M, down -49.39%.

Revenue (ttm)
$64.45M
Revenue Growth
-12.86%
P/S Ratio
5.16
Revenue / Employee
$370,379
Employees
174
Market Cap
388.99M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202370.14M-68.45M-49.39%
Dec 31, 2022138.59M33.84M32.30%
Dec 31, 2021104.75M35.70M51.69%
Dec 31, 202069.06M598.00K0.87%
Dec 31, 201968.46M7.86M12.98%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cross Country Healthcare 1.45B
Amylyx Pharmaceuticals 196.49M
Voyager Therapeutics 163.78M
CVRx, Inc. 47.26M
MaxCyte 45.60M
Silence Therapeutics 21.77M
Fate Therapeutics 13.45M
Nano-X Imaging 10.68M
Revenue Rankings